Page 8 - Reference Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tue, 09 Mar 2021 00:00 UTC US, UK, Canada, Australia, Switzerland and Singapore Will Let New-Variant Vaccines Onto the Market Without Safety or Efficacy Testing identical guidelines for fast-tracking release onto the market of vaccines for the new variants. The countries issued the recommendations under the banner of the 'ACCESS Consortium.' ACCESS is an acronym based on the first letters of the five countries' names. A few days earlier, on February 22, the US Food and Drug Administration (FDA) released a similar set of recommendations. They allow Emergency Use Authorizations (EUAs) for "inve...

Regulatory News: Eurofins (Paris:ERF): empowerDX, a Eurofins subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon.

Eurofins Scientific: Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon empowerDX, a Eurofins (Paris:ERF) subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon. The kits are available to consumers and businesses for purchase without a prescription, enabling greater access to COVID-19 tests, to help the fight against the pandemic. The empowerDX at-home COVID-19 test can detect the virus in both symptomatic and asymptomatic patients. Eurofins Viracor, an infectious disease testing laboratory for m...

Share this article (PRNewsfoto/empowerDX) FRAMINGHAM, Mass., March 10, 2021 /PRNewswire/ -- empowerDX, part of the Eurofins Clinical Diagnostics network, announced the launch of its direct-to-consumer, FDA-emergency use authorized, COVID-19 Home Collection Kit on Amazon. The kits are available to consumers and businesses for purchase without a prescription, enabling greater access to COVID tests, to help the fight against the pandemic. The empowerDX at-home COVID-19 test can detect the virus in both symptomatic and asymptomatic patients.  Eurofins Viracor, an infectious disease testing lab...

Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2 Friday, January 15, 2021 The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa. Eurofins is pleased to announce the following initiatives to support health authorities' variant detection ...